Can Pharmacogenomics Effectively Combat Antimicrobial Resistance?
Did you know that without urgent action, antibiotic resistance could lead to over 10 million deaths annually? This alarming figure highlights the global…
Did you know that without urgent action, antibiotic resistance could lead to over 10 million deaths annually? This alarming figure highlights the global…
Adverse drug reactions (ADRs) pose a substantial challenge within the pharmaceutical sector, with over 106,000 fatalities annually in the United States, according to…
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in underprivileged communities remains a pressing area…
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth study of biological molecules, including genes,…
Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
Explore the complexities of drug resistance genes and their variable impact on phenotypes in our deep dive into genetic influences on treatment outcomes.
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx